Genomic Health

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Genomic Health and buy or sell other stocks, ETFs, and their options commission-free!

About GHDX

Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. 

CEO
Jake A. Orville, MBA
CEOJake A. Orville, MBA
Employees
Employees
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2000
Founded2000
Employees
Employees

GHDX Key Statistics

Market cap
2.38B
Market cap2.38B
Price-Earnings ratio
43.41
Price-Earnings ratio43.41
Dividend yield
Dividend yield
Average volume
1.81M
Average volume1.81M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$86.70
52 Week high$86.70
52 Week low
$50.77
52 Week low$50.77

Stock Snapshot

The current Genomic Health(GHDX) stock price is $63.44, with a market capitalization of 2.38B. The stock trades at a price-to-earnings (P/E) ratio of 43.41.

Genomic Health(GHDX) stock opened on 2026-08-30 at —. The price climbed to — and dipped to —.

Genomic Health(GHDX) shares are trading with a volume of 0, against a daily average of 1.81M.

In the last year, Genomic Health(GHDX) shares hit a 52-week high of $86.70 and a 52-week low of $50.77.

In the last year, Genomic Health(GHDX) shares hit a 52-week high of $86.70 and a 52-week low of $50.77.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.